Andrew Lewington, MD
Leeds, YK UNITED KINGDOM
Dr Andrew Lewington studied medicine as an undergraduate in London before pursuing a career in renal medicine. He studied in Leicester UK and Washington University USA where he worked in Mark Hammermann's laboratory investigating the molecular mechanisms underlying ischaemic acute kidney injury.Dr Lewington was appointed consultant renal physician/honorary senior lecturer at Leeds Teaching Hospitals in 2004. He works as an NHS clinician providing a specialist renal opinion on acutely ill patients on the ICU across Leeds. He was an expert adviser on the UK NCEPOD adding insult to injury AKI study, working from his position on the Renal Association executive committee to improve the care that patients who develop AKI receive. He is the lead author of the 5th Renal Association AKI clinical practice guidelines. During his time in Leeds he has developed collaborative research with an internationally recognised proteomics group. He currently has a nephrology fellow investigating potential proteomic biomarkers of kidney dysfunction in the early phase following kidney transplantation. He is Clinical Sub Dean for the Leeds Teaching Hospitals and is heavily involved in the delivery of undergraduate medical education at the University of Leeds.